Volume 28, Number 7—July 2022
Research Letter
Mental Health Conditions and Severe COVID-19 Outcomes after Hospitalization, United States
Table
Parameter | No. (%) patients |
||||
---|---|---|---|---|---|
No mental health conditions | Anxiety | Depression | Bipolar disorder | Schizophrenia | |
Total |
485,784 (73.1) |
114,902 (17.3) |
96,167 (14.5) |
15,370 (2.3) |
12,304 (1.9) |
Patient characteristics | |||||
Age group, y | |||||
0–17 | 5,415 (1.1) | 608 (0.5) | 584 (0.6) | 97 (0.6) | 25 (0.2) |
18–39 | 61,751 (12.7) | 11,584 (10.1) | 7,598 (7.9) | 2,527 (16.4) | 1,421 (11.5) |
40–49 | 50,127 (10.3) | 11,863 (10.3) | 7,949 (8.3) | 1,996 (13.0) | 1,095 (8.9) |
50–64 | 129,896 (26.7) | 33,511 (29.2) | 26,320 (27.4) | 5,455 (35.5) | 4,251 (34.5) |
65–74 | 101,996 (21.0) | 26,561 (23.1) | 23,756 (24.7) | 3,298 (21.5) | 3,512 (28.5) |
>75 | 136,599 (28.1) | 30,775 (26.8) | 29,960 (31.2) | 1,997 (13.0) | 2,000 (16.3) |
Sex | |||||
F | 218,428 (45.0) | 70,105 (61.0) | 59,327 (61.7) | 9,032 (58.8) | 5,682 (46.2) |
M | 267,356 (55.0) | 44,797 (39.0) | 36,840 (38.3) | 6,338 (41.2) | 6,622 (53.8) |
Race/ethnicity | |||||
Non-Hispanic White | 241,534 (49.7) | 78,634 (68.4) | 67,015 (69.7) | 10,267 (66.8) | 6,409 (52.1) |
Non-Hispanic Black | 93,192 (19.2) | 14,482 (12.6) | 12,736 (13.2) | 2,743 (17.8) | 3,644 (29.6) |
Hispanic | 94,476 (19.4) | 13,783 (12.0) | 9,955 (10.4) | 1,348 (8.8) | 1,158 (9.4) |
Non-Hispanic Asian | 13,989 (2.9) | 1,446 (1.3) | 1,054 (1.1) | 122 (0.8) | 192 (1.6) |
Other or unknown† | 42,593 (8.8) | 6,557 (5.7) | 5,407 (5.6) | 890 (5.8) | 901 (7.3) |
Health insurance | |||||
Medicare | 236,378 (48.7) | 65,874 (57.3) | 61,486 (63.9) | 8,787 (57.2) | 8,264 (67.2) |
Medicaid | 71,593 (14.7) | 15,960 (13.9) | 12,591 (13.1) | 3,908 (25.4) | 2,969 (24.1) |
Private | 133,735 (27.5) | 26,102 (22.7) | 17,015 (17.7) | 1,817 (11.8) | 493 (4.0) |
Other† | 44,078 (9.1) | 6,966 (6.1) | 5,075 (5.3) | 858 (5.6) | 578 (4.7) |
Admission month | |||||
2020 Mar or earlier | 16,773 (3.5) | 2,350 (2.0) | 1,981 (2.1) | 344 (2.2) | 481 (3.9) |
2020 Apr–Jun | 70,536 (14.5) | 12,946 (11.3) | 11,968 (12.4) | 2,578 (16.8) | 2,959 (24.0) |
2020 Jul–Sep | 72,514 (14.9) | 15,462 (13.5) | 12,696 (13.2) | 2,090 (13.6) | 1,749 (14.2) |
2020 Oct–Dec | 149,494 (30.8) | 40,166 (35.0) | 34,329 (35.7) | 4,830 (31.4) | 3,651 (29.7) |
2021 Jan–Mar | 118,438 (24.4) | 29,742 (25.9) | 24,432 (25.4) | 3,686 (24.0) | 2,440 (19.8) |
2021 Apr–Jun | 46,674 (9.6) | 11,904 (10.4) | 9,076 (9.4) | 1,587 (10.3) | 863 (7.0) |
2021 Jul | 11,355 (2.3) | 2,332 (2.0) | 1,685 (1.8) | 255 (1.7) | 161 (1.3) |
Elixhauser Comorbidity Index‡ |
4.0 (9.2) |
6.2 (10.6) |
6.9 (10.8) |
5.7 (9.7) |
6.4 (9.6) |
Hospital characteristics | |||||
Urbanicity | |||||
Urban | 585,009 (88.0) | 429,073 (88.3) | 99,530 (86.6) | 83,505 (86.8) | 13,682 (89.0) |
Rural | 79,947 (12.0) | 56,711 (11.7) | 15,372 (13.4) | 12,662 (13.2) | 1,688 (11.0) |
Region | |||||
East North Central | 8,534 (1.8) | 3,738 (3.3) | 3,193 (3.3) | 487 (3.2) | 427 (3.5) |
East South Central | 79,512 (16.4) | 15,288 (13.3) | 13,917 (14.5) | 2,567 (16.7) | 2,669 (21.7) |
Middle Atlantic | 73,667 (15.2) | 21,736 (18.9) | 18,361 (19.1) | 3,052 (19.9) | 2,236 (18.2) |
Mountain | 19,812 (4.1) | 6,684 (5.8) | 6,544 (6.8) | 747 (4.9) | 520 (4.2) |
New England | 133,540 (27.5) | 30,544 (26.6) | 23,226 (24.2) | 3,778 (24.6) | 2,965 (24.1) |
Pacific | 32,915 (6.8) | 9,537 (8.3) | 7,610 (7.9) | 957 (6.2) | 608 (4.9) |
South Atlantic | 64,156 (13.2) | 13,504 (11.8) | 11,708 (12.2) | 1,753 (11.4) | 1,290 (10.5) |
West North Central | 39,377 (8.1) | 8,394 (7.3) | 6,840 (7.1) | 1,180 (7.7) | 727 (5.9) |
West South Central | 34,271 (7.1) | 5,477 (4.8) | 4,768 (5.0) | 849 (5.5) | 862 (7.0) |
*Values are no. (%) except as indicated. †Missing values, when present, are categorized in the other category. ‡Higher values suggest a higher degree of comorbidity. Expressed as mean (+SD).
Page created: June 13, 2022
Page updated: June 18, 2022
Page reviewed: June 18, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.